πŸ‡ΊπŸ‡Έ FDA
Patent

US 10501800

Breast cancer prognosis

granted A61PA61P35/00A61P43/00

Quick answer

US patent 10501800 (Breast cancer prognosis) held by Regents of the University of Minnesota expires Mon Dec 05 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Regents of the University of Minnesota
Grant date
Tue Dec 10 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 05 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
2
CPC classes
A61P, A61P35/00, A61P43/00, A61P5/32